CVS Health reported first quarter profits were cut almost in half to $1.1 billion compared to the year-ago period thanks to higher costs to treat patients insured by Medicare plans the company sells.
After underperforming its peers in the healthcare sector, shares of CVS Health Co. NYSE: CVS are now nearing a 52-week low price. Underperforming the Health Care Select Sector SPDR Fund NYSEARCA: XLV
CVS Health (NYSE: CVS) will report its Q1 2024 results on Wednesday, May 1. We expect the company's revenues to come in at $90 billion, slightly above the consensus estimate of $89.2 billion.

3 Value Stocks to Buy on the Dip: April 2024

06:00am, Monday, 29'th Apr 2024
Outside of recent rumblings, the sentiment surge in the equities space this year has taken some of the shine off value stocks to buy on the dip. It's not that the concept lost relevance or popularity.
CVS is getting into the business of making copycat biologic drugs, known as biosimilars, to profit directly from blockbusters going generic.

Is This Beaten-Down Dividend Stock a Buy?

11:50am, Saturday, 27'th Apr 2024
CVS Health is facing multiple issues, including lower coronavirus-related revenue. However, the company still has a business that seems built to last.
CVS Health (CVS) closed at $67.18 in the latest trading session, marking a -0.22% move from the prior day.
Staff at CVS Health's unit Omnicare in Las Vegas voted to join the Pharmacy Guild, becoming the first location at the national pharmacy chain to join the union.
Nearly 30 pharmacy staff at the Las Vegas branch of CVS's Omnicare will now join The Pharmacy Guild, which will represent them in labor negotiations with CVS.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for CVS Health (CVS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the
Amid global tensions and some severe market pullbacks, investors might seek refuge in defensive sectors, particularly oversold stocks offering high dividends. With uncertainties looming over geopoliti
The latest trading day saw CVS Health (CVS) settling at $67.33, representing a -0.65% change from its previous close.
The Federal Trade Commission is working to accelerate its inquiry into the prescription-drug middlemen known as pharmacy-benefit managers, while also expanding its scrutiny of drug patents that can ke
CVS Health has been underperforming due to changes in the Medicare Advantage program. Despite the impact on profits in the near term, CVS' long-term growth prospects remain intact. The stock is curren
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE